Fresenius Kabi Deutschland GmbH secures contract for Pharmaceutical Products-Completion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for pharmaceuticals (Open House procedure)

Posted On: 2024-02-26

Germany, Feb. 26 -- Germany based Fresenius Kabi Deutschland GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical Products-Completion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for pharmaceuticals (Open House procedure) . The value of the contract is worth 22100000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Fresenius Kabi Deutschland GmbH secures contract for Pharmaceutical Products-Completion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for pharmaceuticals (Open House procedure)